Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

STAAR Surgical Company - Common Stock (NQ:STAA)

26.26 +0.08 (+0.31%)
Streaming Delayed Price Updated: 10:42 AM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about STAAR Surgical Company - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
STAAR Surgical Board of Directors Reiterates Unanimous Recommendation that STAAR Stockholders Vote “FOR” the Alcon Merger Agreement on WHITE Proxy Card
From STAAR Surgical Company
Via Business Wire
Broadwood Partners: Leading Advisory Firm Glass Lewis Urges STAAR Shareholders to Vote “AGAINST” Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire
STAAR Surgical’s Long-Term Shareholder Says Proposed Deal With Alcon Undervalues The Company
Defender Capital, which owns 1.5% of STAAR’s common stock, highlighted STAAR’s board of directors' rejection of Alcon's previous offer of $58 per share in cash. 
Via Stocktwits
Yunqi Capital, One of STAAR Surgical Company’s Largest Shareholders, Reiterates Its Opposition to the Proposed Merger with Alcon
From Yunqi Capital Limited
Via Business Wire
STAAR Surgical’s Shareholder Yunqi Capital Opposes Proposed Merger With Alcon – Here’s Why
Via Stocktwits
Broadwood Partners Issues Letter to STAAR Surgical’s Board Questioning Its Judgment in Proposed Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire
STAAR Surgical: Independent Industry Analysts Recognize Merits of Alcon Merger, the Value It Provides, and the Downside Risks Facing STAAR on Standalone Basis
From STAAR Surgical Company
Via Business Wire
STAAR Surgical Addresses Broadwood Partners’ Flawed, Misleading, and Misinformed Claims
From STAAR Surgical Company
Via Business Wire
3 Unpopular Stocks We Think Twice About
When Wall Street turns bearish on a stock, it’s worth paying attention. These calls stand out because analysts rarely issue grim ratings on companies for fear their firms will lose out in other... 
Via StockStory
Broadwood Partners Publishes Presentation Detailing Opposition to STAAR Surgical’s Sale to Alcon
From Broadwood Partners, L.P.
Via Business Wire
Alcon and STAAR Surgical Announce Expiration of Hart-Scott-Rodino Waiting Period for Alcon’s Acquisition of STAAR
From Alcon Inc. Investors and STAAR Surgical Company
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates STAA and CYBR on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
STAAR Surgical Publishes Presentation Highlighting Compelling, Certain Cash Value Offered by Alcon Merger and Meaningful Downside Risks if Alcon Merger is not Approved
From STAAR Surgical Company
Via Business Wire
3 Reasons to Avoid STAA and 1 Stock to Buy Instead
STAAR Surgical has been on fire lately. In the past six months alone, the company’s stock price has rocketed 52.2%, reaching $26.75 per share. This was partly thanks to its solid quarterly results, and... 
Via StockStory
Broadwood Partners Files Definitive Proxy Statement Soliciting STAAR Surgical Stockholders to Vote “AGAINST” Proposed Acquisition by Alcon
From Broadwood Partners, L.P.
Via Business Wire
STAAR Surgical Announces Expiration of “Window Shop” Period; No Competing Acquisition Proposals Received
From STAAR Surgical Company
Via Business Wire
Yunqi Capital, 5.1% Holder and One of STAAR Surgical Company’s Largest Shareholders, Announces Intention to Vote Against the Proposed Sale to Alcon
From Yunqi Capital Limited
Via Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PGRE, ETNB, STAA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
STAAR Surgical Board of Directors Unanimously Believes Alcon Merger Maximizes Value for STAAR Stockholders
From STAAR Surgical Company
Via Business Wire
Shareholder Alert: The Ademi Firm Continues to Investigate Whether STAAR Surgical Company Is Obtaining a Fair Price for Its Public Shareholders
From The Ademi Firm
Via Business Wire
Medical Devices & Supplies - Specialty Stocks Q2 Earnings: STAAR Surgical (NASDAQ:STAA) Firing on All Cylinders
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - specialty stocks, including STAAR Surgical (NASDAQ:STAA) and its peers. 
Via StockStory
STAA Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of STAAR Surgical Company is Fair to Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
STAAR Surgical Reiterates Compelling, Premium Cash Value Provided by Alcon Merger
From STAAR Surgical Company
Via Business Wire
1 Healthcare Stock with Solid Fundamentals and 2 We Avoid
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destockings have persisted in the wake of COVID-19,... 
Via StockStory
Topics Stocks
3 Stocks Under $50 Walking a Fine Line
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk than penny stocks, though they’re not immune to... 
Via StockStory
1 Russell 2000 Stock with Exciting Potential and 2 Facing Challenges
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However, these companies often come with higher... 
Via StockStory
1 High-Flying Stock to Target This Week and 2 We Avoid
"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated... 
Via StockStory
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates DAY, WOW, YMAB, STAA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Dayforce, Inc. (NYSE- DAY), WideOpenWest, Inc. (NYSE - WOW), STAAR Surgical Company (Nasdaq – STAA), Y-mAbs Therapeutics, Inc. (Nasdaq – YMAB)
From Brodsky & Smith LLC
Via GlobeNewswire
Predicting the Next Rule Breaker Buyout
Having a stock you own get acquired at a premium feels good at first, but what about the long-term gains that will be left behind when your chips are off the table? 
Via The Motley Fool
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.